Key facts
- Arlo Health’s last known valuation is $17.0M (Mar 2025).
- It has raised $4.0M; the latest was Seed Round ($4.0M) in Mar 2025.
- Notable investors include General Catalyst, 8VC, Upfront Ventures.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Arlo Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Arlo Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Arlo Health
Developer of a health insurance platform designed to provide affordable and employee-centric healthcare coverage. The company offers AI-powered plan management, concierge support, and predictable renewal rates, enabling businesses to control costs, enhance employee satisfaction, and simplify benefits administration.
- Sector
- Financial Services
- HQ
- New York, NY, United States
- Founded
- 2022
- Employees
- 41
- Website
- joinarlo.com/
- Ownership
- Privately Held (backing)
Arlo Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arlo Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arlo Health in its N-PORT filings yet. We sweep new filings monthly.